Viewing Study NCT06389292


Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2025-12-27 @ 12:22 PM
Study NCT ID: NCT06389292
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2024-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module